Results 11 to 20 of about 22,370 (168)

To be or not to be—an incretin or enterogastrone? [PDF]

open access: yesGut, 2006
Glucagon-like peptide 1 does not comfortably fulfil the criterion of a gut derived factor responsible for an enhanced meal related insulin response; it appears logical to add the definition of a "physiological incretin hormone".
Horowitz, M., Nauck, M.
openaire   +3 more sources

Incretin‐based therapies [PDF]

open access: yesJournal of Diabetes, 2012
AbstractIncretin‐based therapies have established a foothold in the diabetes armamentarium through the introduction of oral dipeptidyl peptidase‐4 inhibitors and the injectable class, the glucagon‐like peptide‐1 receptor agonists. In 2009, the American Diabetes Association and European Association for the Study of Diabetes authored a revised consensus ...
Stonehouse, Anthony H   +2 more
openaire   +2 more sources

Incretins or Anti-Incretins? A New Model for the “Entero-Pancreatic Axis” [PDF]

open access: yesHormone and Metabolic Research, 2014
The role of incretins in glucose homeostasis is well known. Yet, in recent years, the sustained weight loss and rapid glycemic control following bariatric surgery has challenged our understanding of the intestinal-pancreatic interaction. This in turn led to the introduction of metabolic surgery, an innovative medical discipline in which a surgical ...
Kamvissi, V   +4 more
openaire   +4 more sources

Profiling the activity of edible European macroalgae towards pharmacological targets for type 2 diabetes mellitus

open access: yesApplied Phycology, 2021
In traditional medicine marine extracts are extensively used as therapies for diabetes. With the increasing rate of incidence of type 2 diabetes mellitus and rising cost of treatments, we investigated the anti-diabetic properties of extracts of common ...
Danielle Calderwood   +9 more
doaj   +1 more source

AN OVERVIEW OF INCRETIN-BASED THERAPIES: PHARMACOLOGY AND FUTURE PERSPECTIVES [PDF]

open access: yesBulletin of Pharmaceutical Sciences. Assiut University, 2022
Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that is released upon nutrient ingestion stimulating insulin secretion, suppressing glucagon secretion, and suppressing appetite and food intake which contribute to glucose homeostasis ...
Randa Ismail   +3 more
doaj   +1 more source

The Role of GLP-1 Signaling in Hypoglycemia due to Hyperinsulinism

open access: yesFrontiers in Endocrinology, 2022
Incretin hormones play an important role in the regulation of glucose homeostasis through their actions on the beta cells and other tissues. Glucagon-like peptide-1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) are the two main incretins
Melinda Danowitz   +2 more
doaj   +1 more source

Genetic variants affecting incretin sensitivity and incretin secretion [PDF]

open access: yesDiabetologia, 2010
Recent genome-wide association studies identified several novel risk genes for type 2 diabetes. The majority of these type 2 diabetes risk variants confer impaired pancreatic beta cell function. Though the molecular mechanisms by which common genetic variation within these loci affects beta cell function are not completely understood, risk variants may
K, Müssig   +4 more
openaire   +2 more sources

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

open access: yesFrontiers in Endocrinology, 2022
The incretin hormone glucagon-like peptide-1 (GLP-1) has received enormous attention during the past three decades as a therapeutic target for the treatment of obesity and type 2 diabetes.
Qiming Tan   +7 more
doaj   +1 more source

Analytic framework for peptidomics applied to large-scale neuropeptide identification

open access: yesNature Communications, 2016
Neuropeptide research is challenged by technical difficulties in identifying new bioactive peptides. Here the authors present an analytical pipeline for large-scale peptidomics applied to the rat hypothalamus, identifying thousands of endogenous ...
Anna Secher   +6 more
doaj   +1 more source

Effect of Prosopis ruscifolia on incretin and insulin secretion in alloxan-induced hyperglycemic rats

open access: yesVitae, 2022
Background: Diabetes mellitus treatment is based on oral hypoglycemic agents or insulin. Medicinal plants constitute an option, and the leaves of Prosopis ruscifolia (Pr) were shown to be effective in reducing glycemia in hyperglycemic animals. Objective:
María Luisa Kennedy   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy